Guidelines For Drug Treatment Of Epilepsy: A Critical Review

dc.creatorGuerreiro C.A.M.
dc.date2008
dc.date2015-06-30T19:17:40Z
dc.date2015-11-26T14:41:33Z
dc.date2015-06-30T19:17:40Z
dc.date2015-11-26T14:41:33Z
dc.date.accessioned2018-03-28T21:48:33Z
dc.date.available2018-03-28T21:48:33Z
dc.identifier
dc.identifierArquivos De Neuro-psiquiatria. , v. 66, n. 3 A, p. 591 - 599, 2008.
dc.identifier0004282X
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-52949086807&partnerID=40&md5=e40a38a2b845ff0fcae6d4843e691543
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/105618
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/105618
dc.identifier2-s2.0-52949086807
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1250892
dc.descriptionThis article critically reviews the role of evidence-based medicine and its guidelines, from their logistic preparation to their interpretation. The strengths and weaknesses of the methodological points are presented, as well the reasons for the extreme popularity of the guidelines in developed countries. The review discusses the main foundations of the most cited guidelines and some recent large studies. Some of the final conclusions are that clinical experience is always an important factor to consider, even in the face of solid evidence, to achieve the best possible management of any particular patient.
dc.description66
dc.description3 A
dc.description591
dc.description599
dc.descriptionFrench, J.A., Kanner, A.M., Bautista, J., Efficacy and tolerability of the new antiepileptic drugs: I: Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy and the American Epilepsy Society (2004) Neurology, 62, pp. 1252-1260
dc.descriptionFrench, J.A., Kanner, A.M., Bautista, J., Efficacy and tolerability of the new antiepileptic drugs: II: Treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2004) Neurology, 62, pp. 1261-1273
dc.descriptionGlauser, T., Ben-Menachen, E., Bourgeois, B., ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (2006) Epilepsia, 47, pp. 1094-1120
dc.descriptionMarson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-1015Marson, A.G., Al-Kharusi, A.M., Alwaidh, M., The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: An unblinded randomised controlled trial (2007) Lancet, 369, pp. 1016-1026
dc.descriptionSackett, D.L., Strauss, S.E., Richardson, W.S., Evidence Based Medicine (2000) How to Practice and Teach EBM, , Edinburgh: Churchill Livingstone
dc.descriptionGlasziou, P., Del Mar, C., Salisbury, J., (2003) Evidence-based Medicine Workbook, , Finding and applying the best research evidence to improve patient care. London: BMJ Books, BMJ Publishing Group
dc.descriptionDans, A.L., Dans, L.F., The need and means for evidence-based medicine in developing countries (2000) ACP J Club, 133, pp. 11-12
dc.descriptionLiberati, A., Moja, L.P., Moschetti, I., Evidence-based medicine: Its contributions in the way we search, appraise and apply scientific information to patient care (2007) Evidence-based Neurology. Management of Neurological Disorders, pp. 3-10. , Candelise L, Hughes R, Liberati A, Uitdehaag BM, Warlow C Eds, Blackwell Publishing, BMJ Books
dc.descriptionMayer, D., (2004) Essential Evidence-based Medicine, , Cambridge: University Press
dc.descriptionDefinition of key terms (1990) Clinical practice guidelines: Directions for a new program, pp. 33-51. , Institute of Medicine, Field MJ, Lohr KN, Eds, Washington, DC: National Academy Press
dc.descriptionCavalcante, A.B., Silva, E., Prática da medicina baseada em evidências: Acessando com eficiência bases de dados eletrônicas. Einstein (2007) Educ Contin Saúde, 5 (4 PART 2), pp. 109-111
dc.descriptionHirtz, D., Ashwal, S., Berg, A., Practice parameter: Evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society (2000) Neurology, 55, pp. 616-623
dc.descriptionHirtz, D., Berg, A., Bettis, D., Practice parameter: Treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society (2003) Neurology, 60, pp. 166-175
dc.descriptionEngel Jr, J., Wiebe, S., French, J., Practice parameter: Temporal lobe and localized neocortical resections for epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons (2003) Neurology, 60, pp. 538-547
dc.descriptionChen, D.K., So, Y.T., Fisher, R.S., Use of serum prolactin in diagnosing epileptic seizures. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (2005) Neurology, 65, pp. 668-675
dc.descriptionHarden, C.L., Huff, J.S., Schwartz, T.H., Neuroimaging in the emergency patient presenting with seizure (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (2007) Neurology, 69, pp. 1772-1780
dc.descriptionKrumholz, D., Wiebe, S., Gronseth, G., Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2007) Neurology, 69, pp. 1996-2007
dc.descriptionNational Institute for Clinical Excellence. Newer drugs for epilepsy in adults. www.nice.org.uk/Docret.asp?d=110081 - accessed May 5, 2008) National Institute for Clinical Excellence. Newer drugs for epilepsy in children. www.nice.org.uk/Docret.asp?d=113359 - accessed May 5, 2008Handbook for the preparation of explicit evidence-based clinical practice guidelines, , www.nzgg.org.nz/download/files/nzgg_guideline_handbook.pdf, New Zealand Guidelines Group, accessed May 5,2008
dc.descriptionWarlow, C., What to do when there is no evidence (2007) Evidence-based Neurology. Management of Neurological Disorders, pp. 11-14. , Candelise L, Hughes R, Liberati A, Uitdehaag BM, Warlow C Eds, Blackwell Publishing, BMJ Books
dc.descriptionDiagnosis and management of epilepsy in adults. Guideline no. 70, Publication, , www.sign.ac.uk/guidelines/fulltext/70/index.html, April 2003
dc.descriptionChadwick, D., Marson, T., Choosing a first drug treatment for epilepsy after SANAD: Randomized controlled trials, systematic reviews, guidelines and treating patients (2007) Epilepsia, 48, pp. 1259-1263
dc.descriptionPanayiotopoulos, C.P., Evidence-based epileptology, randomized controlled trials, and SANAD: A critical clinical view (2007) Epilepsia, 48, pp. 1268-1274
dc.descriptionBrodie, M.J., Perruca, E., Ryvlin, P., Ben-Menachem, E., Meencke, H.J., Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy (2007) Neurology, 68, pp. 402-408
dc.languageen
dc.publisher
dc.relationArquivos de Neuro-Psiquiatria
dc.rightsaberto
dc.sourceScopus
dc.titleGuidelines For Drug Treatment Of Epilepsy: A Critical Review
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución